Effect of systemic parathyroid hormone (1-34) and a β-tricalcium phosphate biomaterial on local bone formation in a critical-size rat calvarial defect model

Yun JI, Wikesjö UME, Borke JL, Bisch FC, Lewis JE, Herold RW, Swiec GD, Wood JC, McPherson III JC. Effect of systemic parathyroid hormone (1–34) and a β‐tricalcium phosphate biomaterial on local bone formation in a critical‐size rat calvarial defect model. J Clin Periodontol 2010; 37: 419–426 doi: 1...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical periodontology 2010-05, Vol.37 (5), p.419-426
Hauptverfasser: Yun, Jonathan I., Wikesjö, Ulf ME, Borke, James L., Bisch, Frederick C., Lewis, Jill E., Herold, Robert W., Swiec, Gary D., Wood, Joseph C., McPherson III, James C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 426
container_issue 5
container_start_page 419
container_title Journal of clinical periodontology
container_volume 37
creator Yun, Jonathan I.
Wikesjö, Ulf ME
Borke, James L.
Bisch, Frederick C.
Lewis, Jill E.
Herold, Robert W.
Swiec, Gary D.
Wood, Joseph C.
McPherson III, James C.
description Yun JI, Wikesjö UME, Borke JL, Bisch FC, Lewis JE, Herold RW, Swiec GD, Wood JC, McPherson III JC. Effect of systemic parathyroid hormone (1–34) and a β‐tricalcium phosphate biomaterial on local bone formation in a critical‐size rat calvarial defect model. J Clin Periodontol 2010; 37: 419–426 doi: 10.1111/j.1600‐051X.2010.01547.x Objective: The objective of this study was to evaluate local bone formation following systemic administration of parathyroid hormone (1–34) (PTH), a surgically implanted synthetic β‐tricalcium phosphate (β‐TCP) bone biomaterial serving as a matrix to support new bone formation. Materials and Methods: Critical‐size, 8 mm, calvarial through‐and‐through osteotomy defects were surgically created in 100 adult male Sprague–Dawley rats. The animals were randomized into five groups of 20 animals each to receive one of the following treatments: PTH (15 μg PTH/kg/day; subcutaneously), PTH/β‐TCP, β‐TCP, or particulate human demineralized freeze‐dried bone (DFDB), and sham‐surgery controls. Ten animals/group were euthanized at 4 and 8 weeks post‐surgery for radiographic and histometric analysis. Results: The histometric analysis showed that systemic PTH significantly enhanced local bone formation, bone fill averaging (±SE) 32.2±4.0% compared with PTH/β‐TCP (15.7±2.4%), β‐TCP (12.5±2.3%), DFDB (14.5±2.3%), and sham‐surgery control (10.0±1.5%) at 4 weeks (p
doi_str_mv 10.1111/j.1600-051X.2010.01547.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_746272000</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>746272000</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4397-85f9a920b5c1ae50c2a3d96aa1ce416be26f806e4dc043ea3391d9aa93dbe1013</originalsourceid><addsrcrecordid>eNqNkc-O0zAQxi0EYrsLr4B8Aw4p4zh_6gsSqrq7oBUgBAL1Yk2cieqS1MFOod134SV4EJ4Jp116BV_GM_6-31j6GOMCpiKeF-upKAASyMWXaQpxCiLPyunuHpucHu6zCUiQSaFKdcbOQ1gDiFJK-ZCdpZDKQszKCfu5aBoyA3cND_swUGcN79HjsNp7Z2u-cr5zG-LPRCKz5xw3NUf--1cyeGuwNXbb8X7lQr_CgXhlXRert9hyt-GtixJejfYmYnCwcWg3EWC8HUZ_Euwt8biNx-Y7How1HT7UuZraR-xBg22gx3f1gn26XHycXyc3765ez1_dJCaTqkxmeaNQpVDlRiDlYFKUtSoQhaFMFBWlRTODgrLaQCYJpVSiVohK1hUJEPKCPT1ye---bSkMurPBUNvihtw26DIr0jIFgH8rpRSgZDkyZ0el8S4ET43uve3Q77UAPaao13oMS49h6TFFfUhR76L1yd2SbdVRfTL-jS0KXh4FP2xL-_8G6zfz94vxGgHJEWBj5rsTAP1XXZSyzPXnt1c6XeaX12K51B_kH8LFvUI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733109371</pqid></control><display><type>article</type><title>Effect of systemic parathyroid hormone (1-34) and a β-tricalcium phosphate biomaterial on local bone formation in a critical-size rat calvarial defect model</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Yun, Jonathan I. ; Wikesjö, Ulf ME ; Borke, James L. ; Bisch, Frederick C. ; Lewis, Jill E. ; Herold, Robert W. ; Swiec, Gary D. ; Wood, Joseph C. ; McPherson III, James C.</creator><creatorcontrib>Yun, Jonathan I. ; Wikesjö, Ulf ME ; Borke, James L. ; Bisch, Frederick C. ; Lewis, Jill E. ; Herold, Robert W. ; Swiec, Gary D. ; Wood, Joseph C. ; McPherson III, James C.</creatorcontrib><description>Yun JI, Wikesjö UME, Borke JL, Bisch FC, Lewis JE, Herold RW, Swiec GD, Wood JC, McPherson III JC. Effect of systemic parathyroid hormone (1–34) and a β‐tricalcium phosphate biomaterial on local bone formation in a critical‐size rat calvarial defect model. J Clin Periodontol 2010; 37: 419–426 doi: 10.1111/j.1600‐051X.2010.01547.x Objective: The objective of this study was to evaluate local bone formation following systemic administration of parathyroid hormone (1–34) (PTH), a surgically implanted synthetic β‐tricalcium phosphate (β‐TCP) bone biomaterial serving as a matrix to support new bone formation. Materials and Methods: Critical‐size, 8 mm, calvarial through‐and‐through osteotomy defects were surgically created in 100 adult male Sprague–Dawley rats. The animals were randomized into five groups of 20 animals each to receive one of the following treatments: PTH (15 μg PTH/kg/day; subcutaneously), PTH/β‐TCP, β‐TCP, or particulate human demineralized freeze‐dried bone (DFDB), and sham‐surgery controls. Ten animals/group were euthanized at 4 and 8 weeks post‐surgery for radiographic and histometric analysis. Results: The histometric analysis showed that systemic PTH significantly enhanced local bone formation, bone fill averaging (±SE) 32.2±4.0% compared with PTH/β‐TCP (15.7±2.4%), β‐TCP (12.5±2.3%), DFDB (14.5±2.3%), and sham‐surgery control (10.0±1.5%) at 4 weeks (p&lt;0.014). Systemic PTH showed significantly enhanced bone formation (41.5±4.0%) compared with PTH/β‐TCP (22.4±3.0%), β‐TCP (21.3±4.4%), and with the sham‐surgery control (23.8±4.2%) at 8 weeks (p&lt;0.025). The DFDB group showed significantly increased bone formation from 4 (14.5±2.3%) to 8 weeks (32.0±3.2%) (p&lt;0.006). The PTH/β‐TCP and β‐TCP groups both showed limited biomaterials resorption. The radiographic analysis was not diagnostic to distinguish local bone formation from the radiopaque β‐TCP biomaterial. Conclusions: Systemic administration of PTH significantly stimulates local bone formation. Bone formation was significantly limited by the β‐TCP biomaterial.</description><identifier>ISSN: 0303-6979</identifier><identifier>EISSN: 1600-051X</identifier><identifier>DOI: 10.1111/j.1600-051X.2010.01547.x</identifier><identifier>PMID: 20236187</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Animals ; Bone Density Conservation Agents - administration &amp; dosage ; Bone Density Conservation Agents - pharmacology ; Bone Matrix - transplantation ; Bone Regeneration - drug effects ; Calcium Phosphates - pharmacology ; Dentistry ; guided bone regeneration ; Injections ; Male ; parathyroid hormone ; Parathyroid Hormone - administration &amp; dosage ; Parathyroid Hormone - pharmacology ; Random Allocation ; rat calvaria model ; Rats ; Rats, Sprague-Dawley ; Skull - surgery ; tissue engineering ; β-tricalcium phosphate</subject><ispartof>Journal of clinical periodontology, 2010-05, Vol.37 (5), p.419-426</ispartof><rights>2010 John Wiley &amp; Sons A/S</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4397-85f9a920b5c1ae50c2a3d96aa1ce416be26f806e4dc043ea3391d9aa93dbe1013</citedby><cites>FETCH-LOGICAL-c4397-85f9a920b5c1ae50c2a3d96aa1ce416be26f806e4dc043ea3391d9aa93dbe1013</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1600-051X.2010.01547.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1600-051X.2010.01547.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20236187$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yun, Jonathan I.</creatorcontrib><creatorcontrib>Wikesjö, Ulf ME</creatorcontrib><creatorcontrib>Borke, James L.</creatorcontrib><creatorcontrib>Bisch, Frederick C.</creatorcontrib><creatorcontrib>Lewis, Jill E.</creatorcontrib><creatorcontrib>Herold, Robert W.</creatorcontrib><creatorcontrib>Swiec, Gary D.</creatorcontrib><creatorcontrib>Wood, Joseph C.</creatorcontrib><creatorcontrib>McPherson III, James C.</creatorcontrib><title>Effect of systemic parathyroid hormone (1-34) and a β-tricalcium phosphate biomaterial on local bone formation in a critical-size rat calvarial defect model</title><title>Journal of clinical periodontology</title><addtitle>J Clin Periodontol</addtitle><description>Yun JI, Wikesjö UME, Borke JL, Bisch FC, Lewis JE, Herold RW, Swiec GD, Wood JC, McPherson III JC. Effect of systemic parathyroid hormone (1–34) and a β‐tricalcium phosphate biomaterial on local bone formation in a critical‐size rat calvarial defect model. J Clin Periodontol 2010; 37: 419–426 doi: 10.1111/j.1600‐051X.2010.01547.x Objective: The objective of this study was to evaluate local bone formation following systemic administration of parathyroid hormone (1–34) (PTH), a surgically implanted synthetic β‐tricalcium phosphate (β‐TCP) bone biomaterial serving as a matrix to support new bone formation. Materials and Methods: Critical‐size, 8 mm, calvarial through‐and‐through osteotomy defects were surgically created in 100 adult male Sprague–Dawley rats. The animals were randomized into five groups of 20 animals each to receive one of the following treatments: PTH (15 μg PTH/kg/day; subcutaneously), PTH/β‐TCP, β‐TCP, or particulate human demineralized freeze‐dried bone (DFDB), and sham‐surgery controls. Ten animals/group were euthanized at 4 and 8 weeks post‐surgery for radiographic and histometric analysis. Results: The histometric analysis showed that systemic PTH significantly enhanced local bone formation, bone fill averaging (±SE) 32.2±4.0% compared with PTH/β‐TCP (15.7±2.4%), β‐TCP (12.5±2.3%), DFDB (14.5±2.3%), and sham‐surgery control (10.0±1.5%) at 4 weeks (p&lt;0.014). Systemic PTH showed significantly enhanced bone formation (41.5±4.0%) compared with PTH/β‐TCP (22.4±3.0%), β‐TCP (21.3±4.4%), and with the sham‐surgery control (23.8±4.2%) at 8 weeks (p&lt;0.025). The DFDB group showed significantly increased bone formation from 4 (14.5±2.3%) to 8 weeks (32.0±3.2%) (p&lt;0.006). The PTH/β‐TCP and β‐TCP groups both showed limited biomaterials resorption. The radiographic analysis was not diagnostic to distinguish local bone formation from the radiopaque β‐TCP biomaterial. Conclusions: Systemic administration of PTH significantly stimulates local bone formation. Bone formation was significantly limited by the β‐TCP biomaterial.</description><subject>Animals</subject><subject>Bone Density Conservation Agents - administration &amp; dosage</subject><subject>Bone Density Conservation Agents - pharmacology</subject><subject>Bone Matrix - transplantation</subject><subject>Bone Regeneration - drug effects</subject><subject>Calcium Phosphates - pharmacology</subject><subject>Dentistry</subject><subject>guided bone regeneration</subject><subject>Injections</subject><subject>Male</subject><subject>parathyroid hormone</subject><subject>Parathyroid Hormone - administration &amp; dosage</subject><subject>Parathyroid Hormone - pharmacology</subject><subject>Random Allocation</subject><subject>rat calvaria model</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Skull - surgery</subject><subject>tissue engineering</subject><subject>β-tricalcium phosphate</subject><issn>0303-6979</issn><issn>1600-051X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkc-O0zAQxi0EYrsLr4B8Aw4p4zh_6gsSqrq7oBUgBAL1Yk2cieqS1MFOod134SV4EJ4Jp116BV_GM_6-31j6GOMCpiKeF-upKAASyMWXaQpxCiLPyunuHpucHu6zCUiQSaFKdcbOQ1gDiFJK-ZCdpZDKQszKCfu5aBoyA3cND_swUGcN79HjsNp7Z2u-cr5zG-LPRCKz5xw3NUf--1cyeGuwNXbb8X7lQr_CgXhlXRert9hyt-GtixJejfYmYnCwcWg3EWC8HUZ_Euwt8biNx-Y7How1HT7UuZraR-xBg22gx3f1gn26XHycXyc3765ez1_dJCaTqkxmeaNQpVDlRiDlYFKUtSoQhaFMFBWlRTODgrLaQCYJpVSiVohK1hUJEPKCPT1ye---bSkMurPBUNvihtw26DIr0jIFgH8rpRSgZDkyZ0el8S4ET43uve3Q77UAPaao13oMS49h6TFFfUhR76L1yd2SbdVRfTL-jS0KXh4FP2xL-_8G6zfz94vxGgHJEWBj5rsTAP1XXZSyzPXnt1c6XeaX12K51B_kH8LFvUI</recordid><startdate>201005</startdate><enddate>201005</enddate><creator>Yun, Jonathan I.</creator><creator>Wikesjö, Ulf ME</creator><creator>Borke, James L.</creator><creator>Bisch, Frederick C.</creator><creator>Lewis, Jill E.</creator><creator>Herold, Robert W.</creator><creator>Swiec, Gary D.</creator><creator>Wood, Joseph C.</creator><creator>McPherson III, James C.</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QP</scope></search><sort><creationdate>201005</creationdate><title>Effect of systemic parathyroid hormone (1-34) and a β-tricalcium phosphate biomaterial on local bone formation in a critical-size rat calvarial defect model</title><author>Yun, Jonathan I. ; Wikesjö, Ulf ME ; Borke, James L. ; Bisch, Frederick C. ; Lewis, Jill E. ; Herold, Robert W. ; Swiec, Gary D. ; Wood, Joseph C. ; McPherson III, James C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4397-85f9a920b5c1ae50c2a3d96aa1ce416be26f806e4dc043ea3391d9aa93dbe1013</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Animals</topic><topic>Bone Density Conservation Agents - administration &amp; dosage</topic><topic>Bone Density Conservation Agents - pharmacology</topic><topic>Bone Matrix - transplantation</topic><topic>Bone Regeneration - drug effects</topic><topic>Calcium Phosphates - pharmacology</topic><topic>Dentistry</topic><topic>guided bone regeneration</topic><topic>Injections</topic><topic>Male</topic><topic>parathyroid hormone</topic><topic>Parathyroid Hormone - administration &amp; dosage</topic><topic>Parathyroid Hormone - pharmacology</topic><topic>Random Allocation</topic><topic>rat calvaria model</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Skull - surgery</topic><topic>tissue engineering</topic><topic>β-tricalcium phosphate</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yun, Jonathan I.</creatorcontrib><creatorcontrib>Wikesjö, Ulf ME</creatorcontrib><creatorcontrib>Borke, James L.</creatorcontrib><creatorcontrib>Bisch, Frederick C.</creatorcontrib><creatorcontrib>Lewis, Jill E.</creatorcontrib><creatorcontrib>Herold, Robert W.</creatorcontrib><creatorcontrib>Swiec, Gary D.</creatorcontrib><creatorcontrib>Wood, Joseph C.</creatorcontrib><creatorcontrib>McPherson III, James C.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><jtitle>Journal of clinical periodontology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yun, Jonathan I.</au><au>Wikesjö, Ulf ME</au><au>Borke, James L.</au><au>Bisch, Frederick C.</au><au>Lewis, Jill E.</au><au>Herold, Robert W.</au><au>Swiec, Gary D.</au><au>Wood, Joseph C.</au><au>McPherson III, James C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of systemic parathyroid hormone (1-34) and a β-tricalcium phosphate biomaterial on local bone formation in a critical-size rat calvarial defect model</atitle><jtitle>Journal of clinical periodontology</jtitle><addtitle>J Clin Periodontol</addtitle><date>2010-05</date><risdate>2010</risdate><volume>37</volume><issue>5</issue><spage>419</spage><epage>426</epage><pages>419-426</pages><issn>0303-6979</issn><eissn>1600-051X</eissn><abstract>Yun JI, Wikesjö UME, Borke JL, Bisch FC, Lewis JE, Herold RW, Swiec GD, Wood JC, McPherson III JC. Effect of systemic parathyroid hormone (1–34) and a β‐tricalcium phosphate biomaterial on local bone formation in a critical‐size rat calvarial defect model. J Clin Periodontol 2010; 37: 419–426 doi: 10.1111/j.1600‐051X.2010.01547.x Objective: The objective of this study was to evaluate local bone formation following systemic administration of parathyroid hormone (1–34) (PTH), a surgically implanted synthetic β‐tricalcium phosphate (β‐TCP) bone biomaterial serving as a matrix to support new bone formation. Materials and Methods: Critical‐size, 8 mm, calvarial through‐and‐through osteotomy defects were surgically created in 100 adult male Sprague–Dawley rats. The animals were randomized into five groups of 20 animals each to receive one of the following treatments: PTH (15 μg PTH/kg/day; subcutaneously), PTH/β‐TCP, β‐TCP, or particulate human demineralized freeze‐dried bone (DFDB), and sham‐surgery controls. Ten animals/group were euthanized at 4 and 8 weeks post‐surgery for radiographic and histometric analysis. Results: The histometric analysis showed that systemic PTH significantly enhanced local bone formation, bone fill averaging (±SE) 32.2±4.0% compared with PTH/β‐TCP (15.7±2.4%), β‐TCP (12.5±2.3%), DFDB (14.5±2.3%), and sham‐surgery control (10.0±1.5%) at 4 weeks (p&lt;0.014). Systemic PTH showed significantly enhanced bone formation (41.5±4.0%) compared with PTH/β‐TCP (22.4±3.0%), β‐TCP (21.3±4.4%), and with the sham‐surgery control (23.8±4.2%) at 8 weeks (p&lt;0.025). The DFDB group showed significantly increased bone formation from 4 (14.5±2.3%) to 8 weeks (32.0±3.2%) (p&lt;0.006). The PTH/β‐TCP and β‐TCP groups both showed limited biomaterials resorption. The radiographic analysis was not diagnostic to distinguish local bone formation from the radiopaque β‐TCP biomaterial. Conclusions: Systemic administration of PTH significantly stimulates local bone formation. Bone formation was significantly limited by the β‐TCP biomaterial.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>20236187</pmid><doi>10.1111/j.1600-051X.2010.01547.x</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0303-6979
ispartof Journal of clinical periodontology, 2010-05, Vol.37 (5), p.419-426
issn 0303-6979
1600-051X
language eng
recordid cdi_proquest_miscellaneous_746272000
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Animals
Bone Density Conservation Agents - administration & dosage
Bone Density Conservation Agents - pharmacology
Bone Matrix - transplantation
Bone Regeneration - drug effects
Calcium Phosphates - pharmacology
Dentistry
guided bone regeneration
Injections
Male
parathyroid hormone
Parathyroid Hormone - administration & dosage
Parathyroid Hormone - pharmacology
Random Allocation
rat calvaria model
Rats
Rats, Sprague-Dawley
Skull - surgery
tissue engineering
β-tricalcium phosphate
title Effect of systemic parathyroid hormone (1-34) and a β-tricalcium phosphate biomaterial on local bone formation in a critical-size rat calvarial defect model
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-20T20%3A02%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20systemic%20parathyroid%20hormone%20(1-34)%20and%20a%20%CE%B2-tricalcium%20phosphate%20biomaterial%20on%20local%20bone%20formation%20in%20a%20critical-size%20rat%20calvarial%20defect%20model&rft.jtitle=Journal%20of%20clinical%20periodontology&rft.au=Yun,%20Jonathan%20I.&rft.date=2010-05&rft.volume=37&rft.issue=5&rft.spage=419&rft.epage=426&rft.pages=419-426&rft.issn=0303-6979&rft.eissn=1600-051X&rft_id=info:doi/10.1111/j.1600-051X.2010.01547.x&rft_dat=%3Cproquest_cross%3E746272000%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733109371&rft_id=info:pmid/20236187&rfr_iscdi=true